The lack of major changes in inflammatory cytokine signaling or viral load suggests that Ang‐2 antagonism has a direct beneficial effect on lung barrier function to reduce injury after viral infection as evidenced by improvement in lung edema and BAL protein. This evidence concerns the gene ANGPT2 and viral infectious disease.